X Labs reports 1,179,230 shares beneficially owned
X Labs Inc. filed an amendment to a Schedule 13G/A reporting beneficial ownership of 1,179,230 shares of Common Stock, representing 8.65% of the class.
Rhea-AI Filing Summary
X Labs Inc. filed an amendment to a Schedule 13G/A reporting beneficial ownership of 1,179,230 shares of Common Stock, representing 8.65% of the class. The filing states this percentage was calculated based on 13,336,392 shares outstanding as of the date hereof.
The filing explains the 1,179,230 figure consists of 879,230 Shares plus 300,000 Shares issuable upon conversion of a convertible loan. It also discloses additional potential shares tied to warrants: 44,283 Shares exercisable within 60 days and 300,000 Shares issuable upon conversion-related warrants, each subject to a blocker provision limiting exercises above 4.99%.
Positive
- None.
Negative
- None.
Insights
Reporting clarifies beneficial ownership and blocker limits.
The amendment states the Reporting Person beneficially owns 1,179,230 shares (8.65%), calculated on 13,336,392 shares outstanding as of the date hereof. It details convertible loan conversion mechanics and warrants with a 4.99% blocker provision.
These disclosures delimit voting and conversion rights and note potential incremental share counts (44,283 and 300,000) that are subject to exercise limitations. Subsequent filings would state if any exercises occur or if blocker thresholds are updated.
Position size and conversion features may affect future supply, timing not specified.
The filing breaks the position into 879,230 currently held shares and 300,000 issuable on conversion of a convertible loan. It separately lists warrants of 44,283 (exercisable within 60 days) and 300,000 tied to the convertible loan.
Cash‑flow treatment and planned exercises are not described in the excerpt; whether these instruments convert or are exercised will determine any near‑term dilutive impact.
Key Figures
Key Terms
blocker provision regulatory
convertible loan financial
beneficially owned regulatory
warrant exercisable within 60 days financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does X Labs (QXL) report as beneficial ownership in this 13G/A amendment?
What is the blocker provision described in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.